Shaheen MA, Idrees M. Evidence-based consensus on the diagnosis, prevention and management of hepatitis C virus disease. World J Hepatol 2015; 7(3): 616-627 [PMID: 25848486 DOI: 10.4254/wjh.v7.i3.616]
Corresponding Author of This Article
Dr. Muhammad Idrees, Associate Professor, Head, Division of Molecular Virology, National Centre of Excellence in Molecular Biology, University of the Punjab, Lahore 53700, Pakistan. idreeskhan@cemb.edu.pk
Research Domain of This Article
Virology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Hepatol. Mar 27, 2015; 7(3): 616-627 Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.616
Evidence-based consensus on the diagnosis, prevention and management of hepatitis C virus disease
Mahrukh Akbar Shaheen, Muhammad Idrees
Mahrukh Akbar Shaheen, Muhammad Idrees, Division of Molecular Virology, National Centre of Excellence in Molecular Biology, University of the Punjab, Lahore 53700, Pakistan
Author contributions: Shaheen MA drafted the manuscript; Idrees M conceived, designed and critically revised the manuscript for important intellectual content.
Conflict-of-interest: The authors declare that they have no competing interests.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Muhammad Idrees, Associate Professor, Head, Division of Molecular Virology, National Centre of Excellence in Molecular Biology, University of the Punjab, Lahore 53700, Pakistan. idreeskhan@cemb.edu.pk
Telephone: +92-42-35293141 Fax: +92-42-35293141
Received: August 25, 2014 Peer-review started: August 26, 2014 First decision: September 19, 2014 Revised: October 1, 2014 Accepted: December 3, 2014 Article in press: December 3, 2014 Published online: March 27, 2015 Processing time: 217 Days and 21.7 Hours
Core Tip
Core tip: The present review describes the evidence-based consensus on the diagnosis, prevention and management of hepatitis C virus (HCV) disease. Besides the conventional techniques more advanced technologies have come to the front that provides best detection with greater ease and specificity. It is of immense importance to prevent this infection among the sexual partners, injecting drug users, mother-to-infant transmission of HCV, household contact, healthcare workers and people who get tattoos and piercing on their skin. Management includes examining the treatment, assessment of hepatic condition before commencing therapy, controlling the parameters upon which dual and triple therapies work, monitoring after treatment and adjusting the co-factors.
